Clinical Trial Update: Phase I/II Study Evaluating AUTO4 in Patients With T Cell Receptor Beta Constant (TRBC)1 Positive T Cell Lymphoma [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for AUTO4 in TRBC1-positive T-cell lymphomas shows Phase 1/2 results with the study terminated and results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaplastic Large Cell Lymphoma
• Angioimmunoblastic T-cell Lymphoma
• Peripheral T-cell Lymphoma Not Otherwise Specified
• T-cell Non-hodgkin Lymphoma

Drugs mentioned

• AUTO4 (AUTO4)

Snippet

Sponsor: Autolus Limited | Conditions: T Cell Non-Hodgkin Lymphoma, Peripheral T-Cell Lymphoma, Not Otherwise Specified | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2026-03-16